Drug Treatment Direction Based on the Molecular Mechanism of Breast Cancer Brain Metastasis.

Pharmaceuticals (Basel) · 2025 · PMC11859690 · PMID 40006075

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Furthermore, inhibiting HER may be significant in the therapeutic management of patients with BCBM, even in case of low HER2 gene expression [ 23 ].

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.